Spatial analyses implicate high stromal tumour-infiltrating CD8+ lymphocytes as a negative predictive marker for chemotherapy in estrogen receptor-positive breast cancer

Understanding immune cell patterns in tumors reveals which patients may benefit most from specific immunotherapies.

What the study was

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.